Invex Therapeutics Ltd
  • Home
  • About Us
    • Company Overview
    • Directors & Management
    • Corporate Governance
  • Development Strategy
  • Investors
    • ASX Announcements
    • Company Reports
    • Presentations
    • Analyst Reports
    • Share Registry
    • Publications
  • Media
    • Articles
  • Careers
    • Current Openings
  • Contact Us
Select Page

Professor Sinclair addresses IIH UK Patient Conference

by Invex Therapeutics | Jul 13, 2019 | Articles-General, media

*Professor Alexandra Sinclair (far right) with attendees of the IIH UK Patient Conference Statement from Shelly Williamson, IIH UK Chair: “The launch of Invex Therapeutics has caused quite a stir of excitement among the IIH community. We shared the announcement...

Invex featured in Yahoo Finance and Motley Fool

by Invex Therapeutics | Jul 11, 2019 | Articles-General, media

Click to view the full...

Prestigious JAMA Neurology medical journal publishes Prof Sinclair’s study into IIH

by Invex Therapeutics | Jul 9, 2019 | media

Click to view the full...

Announcement by University of Birmingham

by Invex Therapeutics | Jul 9, 2019 | Articles-General, media

Click to view the full...

Invex Therapeutics debuts on ASX trading up over 100%

by Invex Therapeutics | Jul 9, 2019 | Articles-General, media

Click to view the full...
« Older Entries

Recent Posts

  • Momentum builds for small cap biotechs
  • Post-placement indigestion an opportunity?
  • Head of Clinical Operations
  • Bioshares – Edition 844 – Invex Therapeutics
  • The Market Herald – Invex taps investors for $26.2m after positive Exenatide trials

Recent Comments

    Archives

    • June 2020
    • May 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • July 2019
    • June 2019

    Categories

    • Articles-General
    • Inactive Openings
    • media

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org